These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6689509)

  • 41. [Intragastric long-term pH measurement for adjusting drug therapy of gastroduodenal ulcer hemorrhage in childhood].
    Schmittenbecher PP
    Monatsschr Kinderheilkd; 1987 Mar; 135(3):158-60. PubMed ID: 3108657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of gastrozepin in erosive-ulcerative diseases of the stomach and duodenum].
    Kukes VG; Blinkov Il; Chekhmakina OV; Krivorotova SP; Karpenko EV
    Klin Med (Mosk); 1984 Jul; 62(7):114-7. PubMed ID: 6548271
    [No Abstract]   [Full Text] [Related]  

  • 43. [Circadian monitoring of intragastric pH in evaluation of efficiency of antisecretory therapy of duodenal ulcer].
    Kolesnikova IIu; Beliaeva GS; Bordin DS
    Klin Med (Mosk); 2002; 80(2):54-6. PubMed ID: 11898725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
    Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment.
    Savarino V; Mela GS; Zentilin P; Cutela P; Mansi C; Vassallo A; Franceschi M; Mela MR; Dallorto E; Celle G
    Am J Gastroenterol; 1993 Jul; 88(7):1088-92. PubMed ID: 8317411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
    Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
    Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
    Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
    Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative treatment of gastric ulcer with pirenzepin, cimetidine and placebo].
    Hoffenberg P; Maggiolo P; Ossa P; Gallo G; Klinger J
    Rev Med Chil; 1985 Jun; 113(6):537-40. PubMed ID: 3914683
    [No Abstract]   [Full Text] [Related]  

  • 49. Antisecretory activity of pirenzepine versus cimetidine in man: a controlled study.
    Procacciante F; Citone G; Montesani C; Ribotta G
    Gut; 1984 Feb; 25(2):178-82. PubMed ID: 6546371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of duodenal ulcer with pirenzepin].
    Hájková J; Klabusay L
    Vnitr Lek; 1983 Mar; 29(3):283-7. PubMed ID: 6344419
    [No Abstract]   [Full Text] [Related]  

  • 51. Maintenance treatment of recurrent duodenal ulceration with pirenzepine.
    Petrillo M; Bianchi Porro G
    Hepatogastroenterology; 1980 Oct; 27(5):369-71. PubMed ID: 7009360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy and selectivity of pirenzepine. Review and commentary.
    Texter EC; Reilly PA
    Scand J Gastroenterol Suppl; 1982; 72():237-46. PubMed ID: 6753118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of almagel, gastrotsepin and food on the acidity and protease activity of the stomach and duodenum in peptic ulcer].
    Mysh VG; Grigor'eva IN
    Ter Arkh; 1989; 61(8):62-5. PubMed ID: 2686073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of gastrozepin on the rate of gastrointestinal tract evacuation in patients with peptic ulcer of the duodenum].
    Likov AF; Guba ES; Belokon' SN; Dzhangirov IP
    Ter Arkh; 1986; 58(2):35-7. PubMed ID: 3754656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of duodenal ulcer with pirenzepin].
    Hoffenberg P
    Rev Med Chil; 1983 Apr; 111(4):419-23. PubMed ID: 6361955
    [No Abstract]   [Full Text] [Related]  

  • 56. Gastric acid and salivary bicarbonate. Is there a relationship in duodenal ulcer patients?
    Namiot Z; Stasiewicz J; Markowski AR; Namiot DB; Jaroszewicz W; Kemona A; Górski J
    Rocz Akad Med Bialymst; 2004; 49():75-9. PubMed ID: 15631318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of 24 h intragastric acidity in duodenal ulcers in children: the importance of monitoring and inhibiting nocturnal acidity.
    Yamashiro Y; Shioya T; Ohtsuka Y; Nagata S; Oguchi S; Shimizu T; Sato M
    Acta Paediatr Jpn; 1995 Oct; 37(5):557-61. PubMed ID: 8533579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Gastrozepin--a new anti-ulcer agent (a review of the literature and the authors' own data)].
    Grigor'ev IIa; Zhivodereov VM; Khar'kovskiĭ NN
    Ter Arkh; 1984; 56(2):43-5. PubMed ID: 6369608
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The degree of gastroesophageal reflux during treatment of the exacerbation of duodenal peptic ulcer by various drugs].
    Geller LI; Griaznova MV; Petrenko VF; Bessonova GA
    Ter Arkh; 1988; 60(2):42-3. PubMed ID: 3368861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.